Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Active, not recruiting · NCT06557889 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-09-11 | NCT06557889 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Claudius Regaud | 39 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 60 |
| Centre Eugène Marquis | Rennes | France | 37 |
| Centre Hospitalier Regional De Marseille | Marseille | France | 2 |
| Centre Jean Perrin | Clermont-Ferrand | France | 37 |
| CHU Amiens | Amiens | France | 49 |
| Chu Bordeaux - Hopital Saint André | Bordeaux | France | 1 |
| CHU de Nantes | Nantes | France | 60 |
| Chu de Nimes | Nîmes | France | 20 |
| CHU Limoges | Limoges | France | 42 |
| CHU Poitiers | Poitiers | France | 70 |
| Clinique Pasteur | Toulouse | France | 23 |
| Institut Sainte Catherine | Avignon | France | 16 |
| IUCT-O | Toulouse | France | 12 |